"Senate plans confirmation hearing for FDA head"
This article was originally published in Clinica
Executive Summary
The US Senate's confirmation hearing for President Clinton's nominee to become the next FDA commissioner, Dr Jane Henney, is tentatively scheduled for September 1. Senator James Jeffords has sent Dr Henney a 26-page letter questioning her on her views on virtually every controversial issue faced by the FDA in recent years and her intentions if confirmed as commissioner. Most of the 140 questions concern the implementation of the Food and Drug Administration Modernization Act, approved last year. Senator Jeffords chairs the Senate Labor and Human Resources Committee which will hold the hearing. He said the questions would "serve as an early indicator" of what Dr Henney can expect to face at the hearing itself. She was asked to respond by August 20.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.